Motor Function Efficacy of Pharmacological Treatments Targeting Energy Metabolism, in Parkinson's Patients

NCT05855577 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease
Gait Analysis
Therapy, Directly Observed
Metabolic Disease

Interventions

DRUG: Terazosin

Sponsor

I.R.C.C.S. Fondazione Santa Lucia

Collaborators

[object Object]
[object Object]